Schedule 13D ownership disclosure
Madrigal Pharmaceuticals Inc
Common Stock, Par Value $0.0001 Per Share · CUSIP: 558868105
Event date: 2025-12-10
- Filing-level shares
- 1,814,831.00
- Percent of class
- 7.8%
- Rebecca Taub, M.D.Reported CIK 0001423898
Shares: 1,814,831.00 · Class: 7.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-120703
- Form type
- SCHEDULE 13D/A
- Filer
- Canticle Pharmaceuticals, Inc.
- CIK
- CIK 1673226
- Filed
- Dec 12, 2025
- Reporting period
- Dec 10, 2025
- Description
- Schedule 13D beneficial ownership